Description

PT-141 (clinically known as Bremelanotide) is a synthetic peptide used primarily to treat sexual dysfunction. Unlike traditional medications that target the vascular system (like Viagra or Cialis, which focus on blood flow), PT-141 works directly within the central nervous system to influence desire and arousal.

​PT-141 is FDA-approved under the brand name Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women. It is prescribed when a persistent lack of sexual desire causes marked personal distress and is not caused by a co-existing medical, mental health, or relationship issue.

Specifications:

• Form: Lyophilized powder
• Unit Size: 10mg
• Storage: Store cool/dry; after reconstitution refrigerate 2–8°C.

Lab Reports:

Legal Disclaimer:

This product is supplied strictly for in vitro laboratory research use only. It is not intended for human consumption, medical use, or veterinary applications. No claims are made regarding safety or efficacy. All information provided is for scientific and educational purposes only. Statements have not been evaluated by the FDA or any other regulatory body. The purchaser assumes all responsibility for the lawful handling, storage, and use of this material in compliance with applicable laws and regulations.